Proteus Regenerative Medicine
Founded 2006
About Proteus Regenerative Medicine
Regenerative Medicine is a rapidly expanding, multidisciplinary set of innovative medical technologies that enable the body to repair, replace, restore and regenerate damaged or diseased cells, tissues and organs. The technologies enabling Regenerative Medicine (RM) are based on more than 50 years of research in stem cell biology, molecular biology, engineering, advanced materials, immunology and genomics. Together these RM technologies are transforming healthcare. The RM field has taken a quantum leap forward with the introduction into the clinic of cell and gene-based therapies, which can cure underlying disease, rather than simply manage symptoms or slow disease progression. RM technologies, with their power to restore and regenerate regardless of the underlying medical indication (e.g. aging, cancer, trauma), are transforming the therapeutic landscape in much the same way as antibiotics and biotech did in previous decades. Antibiotics transformed the treatment of bacterial infections in the 1940s, and in the process created the big pharma industry. Recombinant proteins and monoclonal antibodies produced the next industry step change, and launched the biotech sector.
Company Facts
- Founded: 2006
- Operating status: Operating
- IPO status: Private
- Employees: 1 – 10
- Website: proteusvp.com
- Phone: (650) 529-1932
Social Profiles
Canonical: https://fsome.com/organization/proteus-regenerative-medicine-8308159 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.